These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20662474)

  • 1. [Type 2 diabetes mellitus as a subclinical inflammation].
    Skrha J
    Cas Lek Cesk; 2010; 149(6):277-81. PubMed ID: 20662474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
    Van Campenhout A; Van Campenhout C; Lagrou AR; Abrams P; Moorkens G; Van Gaal L; Manuel-y-Keenoy B
    Diabetes Metab Res Rev; 2006; 22(6):444-54. PubMed ID: 16506275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P; Ghanim H; Chaudhuri A; Mohanty P
    J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postprandial blood glucose as the driving force in pathogenesis of type 2 diabetes].
    Liebl A
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():7-11. PubMed ID: 14694835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature.
    Krebs M; Roden M
    Diabetes Obes Metab; 2005 Nov; 7(6):621-32. PubMed ID: 16219006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
    Helmersson J; Vessby B; Larsson A; Basu S
    Circulation; 2004 Apr; 109(14):1729-34. PubMed ID: 15037525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: diabetes and atherosclerosis--running on a common road.
    Federici M; Lauro R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and the etiology of type 2 diabetes.
    Sjöholm A; Nyström T
    Diabetes Metab Res Rev; 2006; 22(1):4-10. PubMed ID: 15991254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
    Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JA
    Diabetes Care; 2008 Feb; 31 Suppl 2():S161-4. PubMed ID: 18227479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
    Schernthaner GH; Schernthaner G
    Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise training and the antioxidant alpha-lipoic acid in the treatment of insulin resistance and type 2 diabetes.
    Henriksen EJ
    Free Radic Biol Med; 2006 Jan; 40(1):3-12. PubMed ID: 16337874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus.
    Tesauro M; Rizza S; Iantorno M; Campia U; Cardillo C; Lauro D; Leo R; Turriziani M; Cocciolillo GC; Fusco A; Panza JA; Scuteri A; Federici M; Lauro R; Quon MJ
    Metabolism; 2007 Mar; 56(3):413-9. PubMed ID: 17292732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance: from benign to type 2 diabetes mellitus.
    Goldstein BJ
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S3-10. PubMed ID: 14668698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.